Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Atherosclerosis|October 1, 1989
Suppression of alimentary lipemia in man by a prostaglandin analogue (enprostil)K E Schwartz, T SaitoClinical Therapeutics|November 1, 1994
Steady-state pharmacokinetics of enteric-coated naproxen tablets compared with standard naproxen tabletsD Jung, K E SchwartzEndocrinology|March 1, 1981
des-Ser2 salmon calcitonin: a biologically potent synthetic analogK E Schwartz, R C Orlowski, R MarcusThe Journal of Clinical Endocrinology and Metabolism|September 1, 1979
Calcitonin in nonthyroidal cancerK E Schwartz, A R Wolfsen, B Forster, et al.Journal of Clinical Pharmacology|November 8, 2001
Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics of oral prednisone and cortisol suppression in normal womenG M Meno-Tetang, R A Blum, K E Schwartz, et al.Atherosclerosis|May 1, 1988
Reduction of serum lipoproteins in man by the oral administration of a prostaglandin analogue (enprostil)K E Schwartz, B Zaro, P Burton, et al.Digestive Diseases and Sciences|September 1, 1989
A US multicenter study of enprostil 35 micrograms twice daily for treatment of prepyloric, pyloric channel, and duodenal bulb ulcers. Enprostil Study GroupT T Schubert, J A Frizzell, P B Meier, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1988
Suppression of postprandial glucose, insulin, C-peptide, and glucose-dependent insulinotropic peptide (GIP) in man by oral administration of a prostaglandin analogue (enprostil)K E Schwartz, B Zaro, J Reynolds, et al.The American Journal of Gastroenterology|July 1, 1994
Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil)S J Sontag, T G Schnell, E Budiman-Mak, et al.Pageof 1